Targeting myeloid-derived suppressor cells for cancer therapy
The emergence and clinical application of immunotherapy is considered a promising breakthrough in cancer treatment. According to the literature, immune checkpoint blockade (ICB) has achieved positive clinical responses in different cancer types, although its clinical efficacy remains limited in some...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
China Anti-Cancer Association
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/277836c16d664728bdeac45eeca03939 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|